Biotechnology Innovation Organization
@IAmBiotech
Followers
106K
Following
9K
Media
8K
Statuses
38K
I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation. #Biotech
Washington, DC
Joined January 2009
A strong America starts with healthy Americans. For more than 25 years, routine childhood vaccines have helped protect 117 million children—saving lives and strengthening our communities. Learn more about BIO’s Invest in America campaign: https://t.co/nskSS1dtAT
0
0
0
Wishing you a safe, healthy, and spooky Halloween.
0
0
5
He called for bold action to secure the future of U.S. ##biotechnology innovation through: 1️⃣ Strengthening the FDA’s role as the global gold standard, ensuring predictability, scientific integrity, and confidence in the U.S. regulatory system. 2️⃣ Rebuilding America’s
bio.org
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
0
1
2
Yesterday, before the Senate HELP Committee, BIO President & CEO John F. Crowley testified on how U.S. biotechnology can continue to lead the world in innovation that saves lives, strengthens our economy, and protects our nation.
1
0
4
@Newsweek @SenToddYoung Winning the biotech race requires clear regulatory certainty, resilient supply chains, and strong intellectual property protections. It demands national coordination to safeguard innovation and ensure that biotechnology continues to strengthen - and protect - communities across
0
0
3
In @Newsweek, BIO President & CEO John F. Crowley and @SenToddYoung warn that U.S. leadership in #biotechnology - the engine behind 10 million American jobs and nearly 7% of our private-sector GDP - is at risk. Read more:
newsweek.com
America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.
2
2
9
BIO’s Board of Directors gathered in Washington this week for two days of advocacy-packed discussions focused on advancing U.S. biotechnology leadership and protecting patients across America. Today, BIO Board members traveled to Capitol Hill to meet with congressional leaders
1
0
3
“We’re showing up for the people today who need our help using my parents’ values as a guide. I talk about the five C’s, courage, compassion, commitment, care, and cure, and we are committed to all five of those equally perpetually, and that's what we're trying to do.” In
0
0
2
In this morning's #BIOPACE2025 panel "The Next Small Thing," panelists delivered a clear message: patients can’t wait for access to the treatments science has already made possible. https://t.co/9hOxRo6BPd caught up with @KIF1A's Luke Rosen, who shares his daughter’s journey with
0
0
3
Day 2 of #BIOPACE2025 kicks off with discussions on how biomedical breakthroughs are making precision treatments more convenient for patients and how most advanced 21st Century innovations cannot help patients if outdated reimbursement systems stand in the way.
0
1
3
In their fireside chat, BIO President and CEO John F. Crowley sat down with Dr. George Tidmarsh, Director of the Center for Drug Evaluation and Research at the @US_FDA to discuss the director's 30 years+ of experience in biotechnology, clinical medicine, and regulatory science -
1
0
4
Pam Traxel, SVP at @ACSCAN, alongside fellow advocate experts, breaks down the tale of two (vaccine) cities: where we are on vaccine policy vs. development - and tackles how to restore the country’s faith in vaccines amidst growing misinformation. #BIOPACE2025
0
5
5
From #PBM reform and fixing the #340B drug discount system to defending #intellectualproperty and vaccine #innovation - BIO's state advocacy has moved the needle on key industry priorities throughout 2025. BIO's Brian Warren addresses the 2026 state of play. #BIOPACE2025
0
0
2
“PACE is a moment to connect one-on-one with the patient advocates who sit at the heart of our mission to advance patient-focused public policies,” says BIO President and CEO John F. Crowley. “By putting patients first, we stay focused on why we work so hard every day to ensure
0
0
1
Moderated by BIO's SVP of State Government Affairs Patrick J. Plues, the state of play for 2026 state legislative sessions was dissected by advocacy experts Hannah Green, @LungAssociation; Kari Lato, @rx4good; and Northe Saunders, American Families for Vaccines. #BIOPACE2025
0
0
2
Kicking off #BIOPACE2025, @nkartatx CEO Paul Hastings + @TravereRare CEO Eric Dube discussed current policy headwinds, the importance of empathy in leadership, and the responsibility of drug developers to promote equity and accessibility in clinical trial recruitment.
0
0
2